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Abstract 
Metalation of the [7-(1′-1′,2′-closo-C2B10H11)-7,8-nido-C2B9H10]2– dianion with various 
{NiPP2+} or {NiP22+} fragments (PP = chelating diphosphine; P = monodentate phosphine or 
phosphite) leads either to unisomerised 3,1,2-NiC2B9 species or to isomerised 4,1,2-NiC2B9 or 
2,1,8-NiC2B9 species, all with a pendant C2B10 substituent.  The products [1-(1′-1′,2′-closo-
C2B10H11)-3-dppe-3,1,2-closo-NiC2B9H10] (1), [2-(1′-1′,2′-closo-C2B10H11)-4-dppe-4,1,2-
closo-NiC2B9H10] (2), [8-(1′-1′,2′-closo-C2B10H11)-2-dmpe-2,1,8-closo-NiC2B9H10] (3), [1-(1′-
1′,2′-closo-C2B10H11)-3,3-(PMe3)2-3,1,2-closo-NiC2B9H10] (4), [1-(1′-1′,2′-closo-C2B10H11)-
3,3-(PMe2Ph)2-3,1,2-closo-NiC2B9H10] (6), [1-(1′-1′,2′-closo-C2B10H11)-3,3-{P(OMe)3}2-
3,1,2-closo-NiC2B9H10] (9) and [1-(1′-1′,2′-closo-C2B10H11)-2,2-{P(OMe)3}2-2,1,8-closo-
NiC2B9H10] (10) were fully characterised spectroscopically and crystallographically, whilst  
[2-(1′-1′,2′-closo-C2B10H11)-4,4-(PMePh2)2-4,1,2-closo-NiC2B9H10] (8) was characterised 
spectroscopically.  Overall the results suggest that an important factor in a 3,1,2 to 4,1,2 
isomerisation is the relief gained from steric crowding, whereas a 3,1,2 to 2,1,8 isomerisation 
appears to be favoured by strongly electron-donating ligands on the metal.   
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Introduction 
In developing the chemistry of 1,1′-bis(o-carborane),1,2 the trivial name for [1-(1′-1′,2′-closo-
C2B10H11)-1,2-closo-C2B10H11], we recently 3 described the consequences of metalation of one 
of the cages (following single-cage deboronation) with both {CoCp} and {Ru(p-cymene)} 
fragments (Cp = -C5H5; p-cymene = -C10H14, 1-iPr,4-MeC6H4).  With the {Ru(arene)} 
fragment the kinetic product is the unisomerised [1-(1′-1′,2′-closo-C2B10H11)-3-(p-cymene)-
3,1,2-closo-RuC2B9H10], a convenient short form of which may be written as 1-C2B10-3,1,2-
RuC2B9, but this readily gives way under mild thermolysis to the isomerised 8-C2B10-2,1,8-
RuC2B9 species.  Fully analogous compounds are formed with the {CoCp} fragment but depend 
on the source of the metal unit.  Using [CoCpI2(CO)] the product is 1-C2B10-3,1,2-CoC2B9 
whereas using CoCl2/NaCp followed by aerial oxidation results in the formation of 8-C2B10-
2,1,8-CoC2B9.  Although the former does not isomerise to the latter in refluxing toluene, it does 
so if it is reduced and then reoxidised at room temperature.  This perhaps suggests that the 
basicity of the metal fragment might play a role in the ease and nature of the isomerisation of 
metallacarboranes, a concept that has some literature precedence.4 
In this contribution we report the results of metalation of the [7-(1′-1′,2′-closo-C2B10H11)-
7,8-nido-C2B9H10]2– dianion (Fig. 1) derived by single cage deboronation of 1,1′-
bis(o-carborane), with {NiP22+} fragments (P = monodentate phosphine or phosphite) or 
{NiPP2+}fragments (PP = chelating diphosphine) of differing size and basicity, with particular 
interest focussing on the nature of the isomerisation (if any) of the metallacarborane cage and 
the possibility of distinguishing the factors responsible for that isomerisation. 
<Fig. 1 near here> 
Results and Discussion 
The [7-(1′-1′,2′-closo-C2B10H11)-7,8-nido-C2B9H10]2− dianion  is conveniently prepared in situ 
as its lithium salt by treatment of [HNMe3][7-(1′-1′,2′-closo-C2B10H11)-7,8-nido-C2B9H11] 
([HNMe3]I) with n-BuLi in THF.3  Reaction between the dianion and [NiCl2(dppe)] (dppe = 
1,2-diphenylphosphinoethane) affords, following work-up involving thin-layer 
chromatography (TLC) on silica, two isolated products, green 1 and red-purple 2, in moderate 
yield (Scheme 1).  This synthetic approach mirrors that used by Hawthorne and co-workers to 
prepare single-cage bis(phosphine)nickelacarboranes.5 
<Scheme 1 near here> 
Compound 1 was initially analysed by microanalysis and mass spectrometry, both of which 
were consistent with the molecular formula C30H45B19NiP2 [crystals grown from CH2Cl2 
(DCM) and 40-60 petroleum ether (petrol) contain one molecule of DCM of solvation per 
molecule of nickelacarborane].  The 11B{1H} NMR spectrum was relatively uninformative with 
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multiple overlapping resonances which cannot easily be integrated (this turns out to be a 
common feature of most of the compounds reported in this paper).  In the 1H spectrum there 
are, in addition to resonances arising from the dppe ligand, two broad resonances typical of 
CHcage signals, one at relatively high frequency ( 3.08 ppm, assigned to the carborane cage) 
and the other at relatively low frequency ( 1.74 ppm, assigned to the nickelacarborane).  The 
latter appears as a doublet, J = 10.0 Hz, confirmed as arising from coupling to a phosphorus 
nucleus since it collapses to a singlet on broad-band 31P decoupling.  That the two P atoms of 
the dppe ligand are inequivalent is confirmed by the observation of mutual doublets, 2JPP = 25.5 
Hz, at  51.8 and 41.0 ppm in the 31P{1H} spectrum. 
Although these data are fully consistent with 1 being composed of {C2B10H11} and 
{(NiC2B9H10)(dppe)} icosahedral fragments joined by a C–C bond, as expected, they do not 
define the isomeric nature of the nickelacarborane and consequently a structural study was 
undertaken.  Good quality single crystals were obtained from THF/petrol and, although the 
crystallographic analysis revealed evidence for both disordered THF and disordered hexane in 
the lattice, the molecule of 1 is fully ordered. 
A perspective view of a single molecule is shown in Fig. 2.  The nickelacarborane has a 
3,1,2-NiC2B9 architecture arising from simple metalation of the open face of the precursor 
dianion [I-H]2– by the {Ni(dppe)2+} fragment.  Thus compound 1 is [1-(1′-1′,2′-closo-
C2B10H11)-3-dppe-3,1,2-closo-NiC2B9H10] or, in short form, 1-C2B10-3,1,2-NiC2B9.  The 
presence of the bulky carborane substituent on C1 restricts rotation of the {Ni(dppe)} fragment 
about the Ni3…B10 axis rendering the phosphorus atoms inequivalent in solution at room 
temperature, as evidenced by the 31P{1H} NMR spectrum.  Moreover, the carborane substituent 
clearly has an influence on the orientation of the {NiPP} unit.  It is well-established that the 
electronically-controlled orientation of {ML2} fragments in MC2B9 icosahedra is a function of 
the number and positions of the cage C atoms in the carborane ligand face;6 for two adjacent C 
atoms (as in 1) the plane through the {ML2} fragment should lie perpendicular to the vertical 
mirror plane through the C2B9 unit.  In 1 the dihedral angle, , between the plane through 
Ni3P1P2 and the plane through B6B8B10 is 61.87(9)º, not the electronically-preferred 90º.  In 
fact, as Fig. 2 clearly shows, the NiPP plane in 1 lies effectively perpendicular to the plane 
through C1B10B12 so as to minimise steric congestion between the dppe ligand and the 
carborane substituent on C1.  Even then a degree of steric crowding is still observed in that the 
NiPP plane is bent back from perpendicular to the plane through atoms B5B6B11B12B9 
[dihedral angle 10.76(6)º] and Ni3–C1 is significantly longer than Ni3–C2 [2.338(2) versus 
2.112(2) Å]. 
<Fig. 2 near here> 
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Compound 2, a co-product of 1, was assumed to be a geometrical isomer on the basis of 
microanalysis and mass spectrometry.  The main differences in NMR spectra are that in 2 the 
CHcage resonance at low frequency in the 1H spectrum,  1.90 ppm, is a simple singlet, and a 
single (singlet) resonance is observed in the room temperature 31P{1H} spectrum, suggesting 
rotation of the {Ni(dppe)} fragment about the metal-cage axis that is rapid on the NMR 
timescale.  Cooling a solution of 2 in CD2Cl2 freezes out this rotation with the singlet at room 
temperature giving way to mutual doublets, 2JPP = 33.2 Hz, at  69.6 and 60.6 ppm, at 199 K, 
the lowest temperature reached.  Using the standard coalescence temperature method 7 
(Tcoalescence = 221 K) the activation energy for rotation of the {Ni(dppe)} fragment is estimated 
to be ca. 35 kJ mol–1. 
We assume that the metal-phosphine fragment in 2 is able to undergo unrestricted rotation 
at room temperature because the nickelacarborane cage had isomerised with the carborane 
substituent moving away from the Ni-bonded face, and a crystallographic study (Fig. 3) 
confirmed this to be the case.  Compound 2 is [2-(1′-1′,2′-closo-C2B10H11)-4-dppe-4,1,2-closo-
NiC2B9H10] or, in short form, 2-C2B10-4,1,2-NiC2B9, i.e. the nickelacarborane portion of 
crowded molecule 1 has undergone a 3,1,2- to a 4,1,2-NiC2B9 isomerisation to relieve that 
crowding (note that the conventional numbering system for metallacarboranes requires the 
substituted cage C atom to be at vertex 1 in the 3,1,2- isomer 1 but at vertex 2 in the 4,1,2- 
isomer 2).  That it is likely that compound 2 forms from the initial compound 1 in the synthesis 
is supported by the fact that repeated chromatography of green 1 always shows a small amount 
of a faster-moving red-purple band and freshly prepared NMR samples of 1 always show 2 as 
a minor impurity.  Confirmation is provided by the fact that 2 is recovered in 70% isolated yield 
by heating a solution of 1 in THF to reflux for two hours. 
<Fig. 3 near here> 
In 4,1,2-MC2B9 species C2 occupies the lower pentagonal belt of the icosahedron (working 
down from the metal vertex) and is not directly bonded to the metal atom but the direct C1–C2 
connectivity is retained.  Such isomers are relatively rare; there are only ten examples 4a,8 of this 
isomeric form in the Cambridge Structural Database 9 and all but one of these 8e are formed by 
isomerisation of an initial 3,1,2-MC2B9 isomer.  Factors contributing to the reason for this 
isomerisation will be discussed subsequently. 
In 2 the {NiPP} fragment is now bound to a CB4 face.  The expected orientation of the 
metal-phosphine unit is that in which the dihedral angle, , between the NiPP and C1B11B12 
planes is 90º,6 whilst in 2  is found experimentally to be only 56.67(3)º.  Note however that 
calculations were based on a [L2MCB10]– anion and it may be that in 2 the C atom in the lower 
belt has some influence on the orientation observed. 
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The deprotonation of monoanion I– followed by reaction with [NiCl2(dmpe)] (dmpe = 1,2-
dimethylphosphinoethane) affords, following work-up, a yellow-orange compound 3 in 
reasonable yield.  From microanalysis and mass spectrometry it was evident that the 
{Ni(dmpe)2+} fragment had added to the [I-H]2– dianion as expected.  The overall appearance 
of the 11B{1H} NMR spectrum of 3 was clearly different to that for 1 and 2 but spectroscopy 
alone does not define the isomer type to which 3 belongs.  Both CHcage resonances appear as 
singlets in the 1H spectrum with that for the carborane ( ca. 2.2 ppm) overlapping the signals 
from the -CH2-CH2- bridge of the dmpe ligand.  There are two resonances for the CH3 groups 
(overlapping doublets in the 1H spectrum and singlets in the 1H{31P} spectrum) and a singlet in 
the 31P{1H} spectrum, together suggesting that at room temperature the Ni(dmpe) unit is 
undergoing rapid rotation about an asymmetric carborane cage.  As was the case with 
compound 2, cooling the sample arrested that rotation (Tcoalescence = 241 K) affording, for 3, 
mutual doublets in the 31P{1H} spectrum at  48.9 and 45.8 ppm, 2JPP = 48.6 Hz.  The activation 
energy for rotation was estimated as ca. 38 kJ mol–1. 
The structure of compound 3 was established crystallographically (Fig. 4).  Although the 
molecule is partly disordered (only the major occupancies are shown in Fig. 4) the key result 
of the study is clear; the nickelacarborane cage has isomerised into a 2,1,8-NiC2B9 icosahedron, 
making compound 3 [8-(1′-1′,2′-closo-C2B10H11)-2-dmpe-2,1,8-closo-NiC2B9H10] or simply 8-
C2B10-2,1,8-NiC2B9 in short form.  In the metallacarborane the {NiPP} fragment adopts an 
orientation with , the dihedral angle between NiP1P2 and C1B9B12 planes, being 78.97(7)º, 
close to the expected 6 90º. 
<Fig. 4 near here> 
Summarising the results so far, addition of {Ni(dppe)2+} to [I-H]2– results in both 
unisomerised, 1-C2B10-3,1,2-NiC2B9 (1) and isomerised, 2-C2B10-4,1,2-NiC2B9 (2) products, 
and 1 is easily converted into 2 with gentle heat, whilst in contrast addition of {Ni(dmpe)2+} to 
[I-H]2– results in the differently isomerised 8-C2B10-2,1,8-NiC2B9 (3) as the only isolated 
product.  What causes these isomerisations and why do the different chelating diphosphines 
result in different isomerised products? 
Clearly steric crowding between the C2B10H11 substituent on C1 and the diphosphine ligand 
on Ni3 of an unisomerised 3,1,2-NiC2B9 species is likely to contribute to the isomerisation (we 
have already noted the steric crowding in compound 1), since the isomerisation moves the 
carborane substituent down to the lower pentagonal belt.  But relief from steric crowding alone 
cannot account for our results since an unisomerised product (1) was isolated with the larger 
diphosphine dppe (albeit that 1 could readily be isomerised) whereas no such unisomerised 
species was found with the smaller dmpe.  Moreover, since alleviating steric crowding is as 
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effective in a 3,1,2- to 4,1,2- isomerisation as it is for a 3,1,2- to 2,1,8- isomerisation what is it 
that determines which isomerisation path is followed? 
A relevant factor may be the differing donor/acceptor abilities of the diphosphines.  The 
relatively electron-withdrawing dppe ligand will reduce the electron density at the metal centre 
and a 3,1,2- to 4,1,2- isomerisation of the nickelacarborane might help stabilise that since a CB4 
carborane face is expected to be a better donor than a C2B3 face (note, however, that this does 
not necessarily distinguish between a 3,1,2 to 4,1,2 isomerisation and a 3,1,2 to a 2,1,8 
isomerisation, since the carborane face in both isomerised species is CB4).  There are precedents 
for 3,1,2- to 4,1,2- isomerisations driven by reducing the metal electron density; Hawthorne 
and co-workers showed that 1-e oxidation of the anion [3,3′-Ni-{1,2--(CH2)3-1,2-C2B9H9}2]– 
caused a 3,1,2- to 4,1,2- isomerisation in one cage,4a and Stone et al have suggested that the 
dissociation of labile ligands from 3,1,2-PdC2B9 species may facilitate an isomerisation to the 
4,1,2- form.8c  On the other hand the dmpe ligand will be relatively electron-donating, and there 
is literature precedence for an increase in electron density at the metal centre facilitating the 
3,1,2- to 2,1,8- isomerisation process; Hanusa and Todd 4b found that 1-e reduction of 3-Cp-
3,1,2-closo-CoC2B9H11 (Cp = -C5H5) resulted in a 3,1,2- to 2,1,8- isomerisation at relatively 
low temperature, and we recently demonstrated a similar phenomenon with a 1,1′-bis(o-
carborane) analogue of this simple cobaltacarborane.3  We therefore conclude that the electronic 
properties of the diphosphines may play some part in determining the nature of the 
isomerisation process.  That the effect of the net addition of electron density to a 1,2-closo-C2 
icosahedral heteroborane should result in C1–C2 breaking (as observed in the 3,1,2- to 2,1,8- 
isomerisation) is fully consistent with the LUMO of 1,2-closo-C2B10H12 being antibonding 
between the cage C atoms.10 
In a related series of experiments we have also metallated the [I-H]2– dianion with 
{NiP22+}fragments (P = monodentate phosphine) (Scheme 2).  With cis-[NiCl2(PMe3)2] the 
major product is compound 4.  Microanalysis and mass spectrometry were consistent with the 
expected overall formula (C2B10H11)–{(NiC2B9H10)(PMe3)2} and NMR analysis suggested an 
unisomerised 1-C2B10-3,1,2-NiC2B9 architecture, with the presence of mutual doublets (2JPP = 
43.3 Hz) in the 31P{1H} spectrum and the nickelacarborane CHcage resonance showing coupling 
(3JPH = 10.8 Hz) to one P atom, as was observed in the case of compound 1.  A crystallographic 
study (Fig. 5) confirmed this assumption, identifying compound 4 as [1-(1′-1′,2′-closo-
C2B10H11)-3,3-(PMe3)2-3,1,2-closo-NiC2B9H10].  There is disorder between vertices 2 and 4 of 
the nickelacarborane cage [that shown is (just) the major component] but this does not alter the 
isomer type.  The plane through Ni3P1P2 is inclined at 11.74(6)º to that through 
B5B6B11B12B9 (similar to the situation in 1) reflecting the crowding between the carborane 
substituent on C1 and the PMe3 ligands which prevents {NiP2} rotation at room temperature. 
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<Scheme 2 near here> 
<Fig. 5 near here> 
During chromatographic isolation of 4 a trace amount of a purple band was also observed, 
isolation and crystallisation of which revealed both purple and colourless crystals.  The 
colourless material was recovered in only sufficient quantity for mass spectrometry (m/z 350.3) 
and the recording of very weak NMR spectra, and discussion of the nature of this species is 
deferred until compound 7 is described.  The purple material, compound 5, however, was 
analysed by mass spectrometry, NMR spectroscopy and X-ray diffraction.  In the 1H spectrum 
are two broad singlets characteristic of CHcage resonances, one of which is at unusually high 
frequency,  6.13 ppm, and two sets of methyl resonances both showing coupling to P.  In the 
31P{1H} spectrum is a 1:1:1:1 quartet characteristic of P bound to B (1JPB = 145.8 Hz) and a 
singlet.  A 1H-31P HMBC experiment experiments allowed the CH3 resonance at  1.74 ppm to 
be associated with the quartet 31P resonance, and that at  1.36 ppm to be associated with the 
singlet 31P resonance. 
The diffraction study (Fig 6) rationalises these spectroscopic findings.  In the 
nickelacarborane cage (which is of 3,1,2-NiC2B9 architecture) the metal is ligated by one PMe3 
group and one Cl atom, the latter showing H-bonding to the CH atom of the carborane 
substituent on C1 [H2′…Cl, 2.60(2) Å; C2′–H2′…Cl 147.6(15)º; H2′…Cl–Ni3 77.9(4)º], the 
origin of the high-frequency resonance of the CH atom.  A PMe3 group on B8 completes the 
molecule and thus the trace compound 5 is identified as [1-(1′-1′,2′-closo-C2B10H11)-3-Cl-3,8-
(PMe3)2-3,1,2-closo-NiC2B9H9].  A similar single-cage compound, [3-Cl-3,8-(PPh3)2-3,1,2-
closo-NiC2B9H10], afforded by the reaction between [10-PPh3-7,8-nido-C2B9H11]– and cis-
[NiCl2(PPh3)2], has been reported by Hawthorne.5  We believe that a similar reaction is the 
origin of compound 5 involving a phosphacarborane anion which is the deprotonated form of 
the colourless co-product (vide infra).  One interesting point is that in 5 the nickelacarborane 
CHcage atom appears as a singlet in the 1H NMR spectrum, whereas in the other 3,1,2- species 
1 and 4 it couples to one of the P atoms.  The fact that in 5 the sole phosphine is cis to the CHcage 
suggests that in 1 and 4 the coupling is to the trans phosphine. 
<Fig. 6 near here> 
The outcome of the reaction between [I-H]2– and cis-[NiCl2(PMe2Ph)2] was very similar to 
that above.  The major product, compound 6, is a 1-C2B10-3,1,2-NiC2B9 species, specifically 
[1-(1′-1′,2′-closo-C2B10H11)-3,3-(PMe2Ph)2-3,1,2-closo-NiC2B9H10], with inequivalent P atoms 
(2JPP = 39.7 Hz) in the 31P{1H} NMR spectrum and a nickelacarborane CHcage which appears as 
a doublet (3JPH = 14.0 Hz) in the 1H NMR spectrum, presumably from coupling to the trans 
phosphine.  The asymmetry of the nickelacarborane cage is confirmed by the observation of 
four separate resonances for the CH3 groups, doublets in the 1H spectrum collapsing to singlets 
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on 31P decoupling.  A crystallographic study of 6 (Fig. 7) is fully consistent with this spectral 
analysis.  There is some disorder between vertices 2 and 4 of the nickelacarborane cage with 
the major component shown in the Figure.  The key features of the structure resemble those of 
compounds 1 and 4; the NiP1P2 plane is twisted away from its expected 6 orientation 
perpendicular to the plane through B6B8B10 [ = 54.3(6)º] by the steric demands of the 
carborane substituent bonded to C1 and also bent back from perpendicular to the plane through 
B5B6B11B12B9 [by 12.2(3)º] for the same reason. 
<Fig. 7 near here> 
Also similar to the reaction between [I-H]2– and cis-[NiCl2(PMe3)2], a minor purple band 
was also isolated by TLC following the reaction between the dianion and cis-[NiCl2(PMe2Ph)2] 
and, again, crystallisation of this afforded both colourless and purple products.  NMR analysis 
of the purple component strongly suggests that it is a direct analogue of compound 5. 
This time the colourless compound, 7, was isolated in sufficient quantity for complete 
characterisation.  Microanalysis and mass spectrometry are consistent with the formula 
C12H32B19P.  The 11B{1H} NMR spectrum contains two low frequency resonances typical of a 
nido-C2B9 anion,11 and a 1H{11B} experiment revealed evidence for a bridging B-H-B atom at 
 -1.93 ppm.  Finally, there is a single resonance in the 31P{1H} spectrum appearing as a 1:1:1:1 
quartet (i.e. P bound to B) with 1JPB = 148.5 Hz.  All these features are fully supported by the 
results of a crystallographic study of 7 (Fig. 8).  The unprimed cage has not been metalated, 
rather it has a PMe2Ph group bound at B10 and a -H atom between B9 and B10.  Thus 
compound 7 is [7-(1′-1′,2′-closo-C2B10H11)-10-(PMe2Ph)-7,8-nido-C2B9H10].  Related species 
have been reported by Zakharkin et al. 12 and Todd et al.13  With the nature of compound 7 now 
established we return to the colourless component of the purple band recovered following the 
reaction between [I-H]2– and cis-[NiCl2(PMe3)2].  Weak 1H, 31P{1H} and 11B{1H} spectra 
recorded for this species are all analogous to those observed for 7 and thus we are confident 
that this earlier colourless product has an analogous structure.  This also fits with the envelope 
centred on m/z 350.3 in its mass spectrum.  Based on literature precedence,5 we assume that 
compound 5 is the result of reaction between the deprotonated form of this species and cis-
[NiCl2(PMe3)2] (vide supra). 
<Fig. 8 near here> 
The reaction between [I-H]2– and cis-[NiCl2(PMePh2)2] gave a different type of product to 
those obtained using the PMe3 and PMe2Ph analogues.  Although microanalysis and mass 
spectrometry are consistent with the only isolatable product, compound 8, being (C2B10H11)–
{(NiC2B9H10)(PMePh2)2} [microanalysis assumes 0.5DCM per molecule of 8, for which there 
is evidence from 1H NMR spectra recorded in [(CD3)2CO], the observation of a single (singlet) 
resonance in the 31P{1H} spectrum implies isomerisation of the nickelacarborane has occurred.  
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Frustratingly compound 8 could not be persuaded to crystallise but we are confident that the 
nickelacarborane cage is the 4,1,2- isomer and not the 2,1,8- isomer from the similarity of the 
11B{1H} NMR spectra of 8 and 2 and the dissimilarity of the spectra of 8 and 3 (Fig. 9).  We 
therefore suggest that 8 is [2-(1′-1′,2′-closo-C2B10H11)-4,4-(PMePh2)2-4,1,2-closo-NiC2B9H10]. 
<Fig. 9 near here> 
Compounds 4, 6 and 8 represent a series of molecules in which the monodentate phosphine 
ligands are varied from PMe3 to PMe2Ph to PMePh2.  Compounds 4 and 6 are unisomerised 
(3,1,2-NiC2B9) whilst in 8 the nickelacarborane cage is isomerised to a 4,1,2-NiC2B9 form.  
Clearly, as the series PMe3, PMe2Ph, PMePh2 is progressed there is an increase in both the 
electon-withdrawing capability and the size of the phosphine and this makes it difficult, if not 
impossible, to know which of these factors is primarily responsible for the isomerisation. 
In view of this we have targeted trimethylphosphite, P(OMe)3, as an important ligand in this 
work.  Since P(OMe)3 is smaller than PMe3 but more electron-withdrawing than PMePh2 14 its 
use may help distinguish the relative importance of the steric and electronic properties of the 
exopolyhedral ligand in the isomerisation process.  However, we are not aware of a simple 
nickel halide bis(trimethylphosphite) compound [NiX2{P(OMe)3}2] which could be reacted 
with [I-H]2– to determine if P(OMe)3 effects an isomerisation.  The closest species in the 
literature are the tris(trimethylphosphite) [NiI2{P(OMe)3}3] for which a structure is reported 15 
but no synthetic details given, and the bis(triethylphosphite) [NiBr2{P(OEt)3}2] for which the 
reverse is true.16  On the other hand Wallbridge and co-workers have shown that P(OMe)3 will 
displace tmeda (tmeda = Me2NCH2CH2NMe2) from [3-tmeda-3,1,2-closo-PdC2B9H11] to afford 
[3,3-{P(OMe)3}2-3,1,2-closo-PdC2B9H11].17  Again the simple species [NiCl2(tmeda)] appears 
to be unknown but a constitutional isomer, [Ni3Cl5(tmeda)3]Cl, is well-characterised.18 
Accordingly, we have followed two approaches to metalation of [I-H]2– with a 
{Ni[P(OMe)3]22+} fragment (Scheme 3).  Firstly, we prepared cis-[NiBr2{P(OMe)3}2] in ca. 
71% yield, following the method reported for [NiBr2{P(OEt)3}2],16 and added this to [I-H]2– in 
the standard way.  Following work-up the purple compound 9 was isolated in modest yield.  
Following initial characterisation by microanalysis and mass spectrometry, compound 9 was 
analysed by NMR spectroscopy.  The presence of two mutual doublets (2JPP = 118.2 Hz) in the 
31P{1H} NMR spectrum and a doublet (3JPH = 10.0 Hz) for the metallacarborane CcageH 
resonance in the 1H NMR spectrum, the latter collapsing to a singlet on 31P decoupling, 
indicated a 1-C2B10-3,1,2-NiC2B10 species by analogy with the spectroscopic features of 1, 4, 
and 6.  The inequivalence of the phosphite ligands in 9 was also confirmed by the observation 
of two resonances assigned to OCH3 units in the 1H{31P} spectrum.  These results are fully 
consistent with the solid-state structure established for 9 (Fig. 10).  Thus compound 9 is [1-(1′-
1′,2′-closo-C2B10H11)-3,3-{P(OMe)3}2-3,1,2-closo-NiC2B9H10].  The plane through Ni3P1P2 
subtends a dihedral angle of 55.13(12)° with that through B6B8B10 and is bent back from 
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perpendicular to the plane through B5B6B11B12B9 by 7.83(9)° to accommodate the steric bulk 
of the carborane substituent.  An interesting feature of the structure is the presence of a 
hydrogen bond between O21 and H2′ [H2′…O21, 2.19(4) Å; C2′–H2′…O21 170(3)º; 
H2′…O21–P2 106.5(9)º, H2′…O21–C21 120.3(9)º]. 
<Scheme 3 near here> 
<Fig. 10 near here> 
Secondly, we have reacted [I-H]2– with 0.5 equivalents of [Ni3Cl5(tmeda)3]Cl followed by 
addition of an excess of P(OMe)3.  On work-up this affords purple 9 as a minor component but 
also a new species, yellow compound 10, as the major isolated product.  By microanalysis and 
mass spectrometry it is clear that compounds 9 and 10 are both C10H39B19O6NiP2, but 
spectroscopically they are quite different.  In the 31P{1H} NMR spectrum of 10 are two 
overlapping doublet resonances which suggests (by analogy with 1, 4, 6 and 9) that the 
carborane substituent is on the upper face of the metallacarborane cage, adjacent to the metal 
fragment.  On the other hand, in the 1H NMR spectrum the lower-frequency cage CH resonance 
(that of the metallacarborane cage,  2.23 ppm) appears as a singlet, unlike the doublets in 1, 4, 
6 and 9 due to 31P coupling. 
The issue was resolved by a crystallographic study of 10 (Fig. 11).  Compound 10 is [1-(1′-
1′,2′-closo-C2B10H11)-2,2-{P(OMe)3}2-2,1,8-closo-NiC2B9H10].  Thus the nickelacarborane 
cage has isomerised to afford a 1-C2B10-2,1,8-NiC2B9 species in which, in contrast to the 
situation in compound 3, the C atom of the nickelacarborane not bearing the carborane 
substituent has migrated to the lower pentagonal face.  Although not unknown,19 this is a 
relatively unusual type of isomerisation for a C-monosubstituted metallacarborane and clearly 
it is not driven by steric crowding.  The key structural features of 10 are that the NiP1P2 plane 
is effectively perpendicular to the plane through C1B9B12 [ = 84.70(6)°] and slightly bent 
back from perpendicular to the plane through B4B5B10B12C8 [2.98(5)°], and there is again an 
H-bond between the carborane substituent and one phosphite ligand [H2′…O23, 2.351(19) Å; 
C2′–H2′…O23 158.0(15)º; H2′…O23–P2 99.5(5)º, H2′…O23–C23 128.0(5)º]. 
<Fig. 11 near here> 
What do the structures of 9 and 10 infer regarding what drives the 3,1,2 to 4,1,2 and 3,1,2 
to 2,1,8 isomerisations?  In 9 the phosphite ligands are small (smaller that PMe3, PMe2Ph and 
PMePh2) and strongly electron-withdrawing, and the nickelacarborane cage has not isomerised 
whereas in compound 8 (PMePh2 ligands) it clearly has.  This tends to suggest that for a 3,1,2 
to 4,1,2 isomerisation relief from steric crowding is a more important driver than is the electron-
withdrawing character of the exopolyhedral ligands.  We do not believe that the hydrogen bond 
between O21 and H2′ in 9 is important in preventing isomerisation since there is evidence that 
it is relatively weak [ for H2′ is only 4.59 ppm in 9, not substantially higher frequency than 
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those in 3 (4.29), 6 (4.00) and 8 (4.13) in which there is no H-bonding] and, moreover, if the 
H-bonding is retained in solution, it must be fluctional between all three OCH3 groups on the 
P2 ligand (since these are equivalent by NMR) which also argues against it being very strong. 
In contrast, the 1-C2B10-2,1,8-NiC2B9 architecture of 10 strongly implies that the major 
influence driving a 3,1,2 to 2,1,8 isomerisation is the electron-donating character of the 
exopolyhedral ligands as opposed to steric crowding.  We believe that this isomerisation takes 
place when the metallacarborane is metalated by a {Ni(tmeda)} fragment (i.e. before 
subsequent displacement of the tmeda by phosphite – the small amount of 9 that is isolated with 
10 presumably results from ligand substitution before isomerisation).  Certainly, only an 
electronically-driven isomerisation can explain why the unsubstituted C(H) vertex in 10 has 
moved to the lower pentagonal belt whilst the substituted C(C2B10) remains in the upper belt.20 
Finally we note that these tentative conclusions drawn from the trimethylphosphite work are 
fully consistent with the results of the chelating diphosphine work; using the larger dppe ligand 
resulted in a 3,1,2 to 4,1,2 isomerisation whilst the more compact, electron-donating dmpe 
ligand resulted in a 3,1,2 to 2,1,8 isomerisation. 
Conclusions 
The factors influencing the isomerisation proceses of heteroboranes have long been the subject 
of keen interest.  This study of the products of the metalation of singly-deboronated 1,1-bis(o-
carborane) with nickel-phosphine and –phosphite fragments suggests that the relief of steric 
crowding is important in driving the 3,1,2 to 4,1,2-NiC2B9 isomerisation, whereas for the 
alternative 3,1,2 to 2,1,8-NiC2B9 isomerisation the basicity of the exopolyhedral ligands 
appears to be key. 
Acknowledgements 
We thank Heriot-Watt University for a James Watt Studentship awarded to DM, the EPSRC 
for support of WYM (grant no. EP/I031545/1) and Dr D. Ellis for VT NMR spectra. 
Experimental 
Synthesis 
Experiments were performed under dry, oxygen free N2, using standard Schlenk techniques, 
although subsequent manipulations were sometimes performed in the open laboratory.  THF 
and petrol were freshly distilled under nitrogen from sodium wire immediately before use whilst 
DCM was purified in an MBRAUN SPS-800.  All solvents were degassed (3×freeze-pump-
thaw cycles) before use.  Deuterated solvents were stored over 4 Å molecular sieves.  
Preparative TLC employed 20×20 cm Kieselgel F254 glass plates and column chromatography 
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used 60 Å silica as the stationary phase.  NMR spectra at 400.1 MHz (1H), 162.0 MHz (31P) or 
128.4 MHz (11B) were recorded on a Bruker DPX-400 spectrometer from CDCl3, CD2Cl2 or 
(CD3)2CO solutions, at room temperature unless otherwise stated.  Electron impact mass 
spectrometry (EIMS) was carried out using a Finnigan (Thermo) LCQ Classic ion trap mass 
spectrometer at the University of Edinburgh.  Elemental analyses were conducted using an 
Exeter CE-440 elemental analyser.  The starting materials 1,1-bis(o-carborane),21 its 
deboronated derivative [HNMe3][7-(1′-1′,2′-closo-C2B10H11)-7,8-nido-C2B9H11] ([HNMe3]I),3 
[NiCl2(dmpe)] 22 cis-[NiCl2(PMe3)2],23 cis-[NiCl2(PMe2Ph)2],23 cis-[NiCl2(PMePh2)2] 23 and 
[Ni3Cl5(tmeda)3]Cl 18 were prepared by literature methods or slight variations thereof.  
[NiCl2(dppe)] and all other reagents were supplied commercially. 
[1-(1′-1′,2′-closo-C2B10H11)-3-dppe-3,1,2-closo-NiC2B9H10] (1) and [2-(1′-1′,2′-closo-
C2B10H11)-4-dppe-4,1,2-closo-NiC2B9H10] (2).  Salt [HNMe3]I (0.20 g, 0.59 mmol) was 
dissolved in dry THF (20 mL), n-BuLi (0.51 mL of 2.5M solution in hexanes, 1.29 mmol) was 
added dropwise at 0 °C and the solution was stirred at room temperature for 2 hr.  The pale 
yellow THF solution of Li2[7-(1′-1′,2′-closo-C2B10H11)-7,8-nido-C2B9H10] was frozen at -196 
°C, [NiCl2(dppe)] (0.34 g, 0.64 mmol) was added and the reaction mixture stirred overnight at 
room temperature, during which time the solution changed to green-purple.  THF was removed 
in vacuo and the crude mixture dissolved in DCM and filtered through Celite®.  Preparative 
TLC using an eluent system of DCM and petrol (50:50) afforded a green band (Rf = 0.55) 
subsequently identified as [1-(1′-1′,2′-closo-C2B10H11)-3-dppe-3,1,2-closo-NiC2B9H10] (1) 
(0.089 g, 23%) and a red-purple band (Rf = 0.66) identified as [2-(1′-1′,2′-closo-C2B10H11)-4-
dppe-4,1,2-closo-NiC2B9H10] (2) (0.068 g, 15%). 
1: C30H45B19NiP2 requires C 49.2, H 6.20; C30H45B19NiP2·CH2Cl2 requires C 45.6, H 5.80.  
Found for 1·CH2Cl2: C 45.8, H 5.31%.  11B{1H} NMR [(CD3)2CO],  5.9 (1B), 2.6 (1B), -2.8 
(1B), -5.3 to -18.3 multiple overlapping resonances with maxima 
at -5.3, -8.3, -10.2, -11.5, -12.9, -14.3, -15.8, -18.3 (total integral of last eight resonances 16B).  
1H NMR (CD2Cl2),  7.97-7.30 (m, 20H, C6H5), 3.08 (s, 1H, CHcage), 2.52-2.22 (m, 4H, 
P{CH2}2P), 1.74 (d, 3JPH = 10.0 Hz, 1H, CHcage).  1H{31P} NMR (CD2Cl2),  7.97-7.30 (m, 20H, 
C6H5), 3.08 (s, 1H, CHcage), 2.52-2.22 (m, 4H, P{CH2}2P), 1.75 (s, 1H, CHcage).  31P{1H} NMR 
[(CD3)2CO],  51.8 (d, 2JPP = 25.5 Hz, 1P), 41.0 (d, 2JPP = 25.5 Hz, 1P).  EIMS, envelope centred 
on m/z 731.5 (M+). 
2: C30H45B19NiP2 requires C 49.2, H 6.20; C30H45B19NiP2·CH2Cl2 requires C 45.6, H 5.80.  
Found for 2 C 45.4, H 6.19%.  11B{1H} NMR [(CD3)2CO],  4.7 (1B), -3.4 to -15.8 multiple 
overlapping resonances with maxima at -3.4, -4.1, -6.9, -10.6, -13.2, -15.8 (total integral of last 
six resonances 18B).  1H NMR [(CD3)2CO],  7.92-7.78 (m, 8H, C6H5), 7.58-7.45 (m, 12H, 
C6H5), 3.95 (s, 1H, CHcage), 2.85-2.70 (m, 4H, P{CH2}2P), 1.90 (s, 1H, CHcage).  31P{1H} NMR 
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[(CD3)2CO],  63.9 (s).  31P{1H} NMR (CD2Cl2, 199 K),  69.6 (d, 2JPP = 33.2 Hz, 1P), 60.6 (d, 
2JPP = 33.2 Hz, 1P).  EIMS, envelope centred on m/z 731.5 (M+). 
Thermal isomerisation of 1 to 2.  Compound 1 (0.020 g, 0.027 mmol) was dissolved in 
THF (20 mL) and the solution heated at reflux for 2 hr.  The solvent was removed and the 
product purified by preparative TLC using an eluent system of DCM:petrol (50:50) to afford a 
red-purple band at Rf = 0.66 identified as 2 (0.014 g, 70 %) by 1H, 31P and 11B NMR 
spectroscopies. 
[8-(1′-1′,2′-closo-C2B10H11)-2-dmpe-2,1,8-closo-NiC2B9H10] (3).  Salt [HNMe3]I (0.20 g, 
0.59 mmol) was deprotonated with n-BuLi (0.51 mL of 2.5M solution in hexanes, 1.29 mmol) 
as above and then frozen at -196 °C.  [NiCl2(dmpe)] (0.18 g, 0.64 mmol) added and the reaction 
mixture stirred overnight at room temperature during which time the solution changed to 
orange-yellow.  All volatiles were removed in vacuo and the crude mixture dissolved in DCM 
and filtered through Celite®.  Following spot TLC (DCM:petrol, 50:50) purification by 
preparative TLC using the same eluent gave yellow-orange product (Rf = 0.44) subsequently 
identified as [8-(1′-1′,2′-closo-C2B10H11)-2-dmpe-2,1,8-closo-NiC2B9H10] (3) (0.090 g, 35%).  
C10H37B19NiP2 requires C 24.8, H 7.71.  Found for 3 C 23.6, H 7.79%.  11B{1H} NMR 
[(CD3)2CO],  -3.6 (2B), -4.7 (1B), -6.0 (1B), -7.6 (1B), -10.6 (8B), -13.5 (2B), -16.9 (1B), -18.7 
(1B), -20.3 (2B).  1H NMR [(CD3)2CO],  4.29 (s, 1H, CHcage), 2.39-2.12 (m, 4H, P{CH2}2P 
and s, 1H, CHcage), 1.65-1.60 (m, 12H, CH3).  1H{31P} NMR [(CD3)2CO],  4.28 (s, 1H, CHcage), 
2.28-2.14 (m, 4H, P{CH2}2P and s, 1H, CHcage), 1.64 (s, 6H, CH3), 1.63 (s, 6H, CH3).  31P{1H} 
NMR [(CD3)2CO],  46.2 (s).  31P{1H} NMR (CD2Cl2, 203 K),  48.9 (d, 2JPP = 48.6 Hz, 1P), 
45.8 (d, 2JPP = 48.6 Hz, 1P).  EIMS, envelope centred on m/z 483.4 (M+). 
[1-(1′-1′,2′-closo-C2B10H11)-3,3-(PMe3)2-3,1,2-closo-NiC2B9H10] (4) and [1-(1′-1′,2′-
closo-C2B10H11)-3-Cl-3-PMe3-8-PMe3-3,1,2-closo-NiC2B9H9] (5).  Salt [HNMe3]I (0.20 g, 
0.59 mmol) was treated with n-BuLi (0.51 mL of 2.5M solution in hexanes, 1.29 mmol) as 
above and frozen at -196 °C.  Cis-[NiCl2(PMe3)2] (0.18 g, 0.64 mmol) was added and the 
reaction mixture stirred overnight at room temperature, during which time the solution turned 
green.  THF was removed in vacuo and the crude mixture was dissolved in DCM and filtered 
through Celite®.  Preparative TLC using an eluent system of DCM and petrol, 50:50, afforded 
a green band (Rf = 0.50) subsequently identified as [1-(1′-1′,2′-closo-C2B10H11)-3,3-(PMe3)2-
3,1,2-closo-NiC2B9H10] (4) (0.070 g, 24%).  C10H39B19NiP2 requires C 24.7, H 8.10.  Found for 
4 C 24.4, H 8.30%.  11B{1H} NMR (CDCl3),  0.5 (1B), -1.4 (1B), -2.6 (1B), -4.6 (1B), -7.7 
to -16.4 multiple overlapping resonances with maxima at -7.7, -10.3, -12.4, -15.4, -16.4 (total 
integral of last five resonances 14B), -21.8 (1B).  1H NMR (CDCl3),  3.99 (s, 1H, CHcage), 1.64 
(d, 3JPH = 10.8 Hz, 1H, CHcage), 1.55 (d, 2JPH = 9.6 Hz, 9H, CH3), 1.49 (d, 2JPH = 8.4 Hz, 9H, 
CH3).  1H{31P} NMR (CDCl3),  3.99 (s, 1H, CHcage), 1.64 (s, 1H, CHcage), 1.52 (s, 9H, CH3), 
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1.47 (s, 9H, CH3).  31P{1H} NMR (CDCl3),  -9.9 (d, 2JPP = 43.3 Hz, 1P), -24.9 (d, 2JPP = 43.3 
Hz, 1P).  EIMS, envelope centred on m/z 485.3 (M+). 
A trace amount of purple band (Rf = 0.70) was also obtained, crystallisation of which 
revealed both purple and colourless solids, the former in sufficient amount for it to be identified 
as [1-(1′-1′,2′-closo-C2B10H11)-3-Cl-3,8-(PMe3)2-3,1,2-closo-NiC2B9H9] (5).  11B{1H} NMR 
(CDCl3),  -1.9 (1B), -3.3 (1B), -4.0 (1B), -5.3 (1B), -6.5 (1B), -8.1 to -15.2 multiple 
overlapping resonances with maxima at -9.6, -10.6, -12.6 (total integral of last three resonances 
10B), -15.9 (1B), -17.7 (2B), -25.4 (1B).  1H NMR (CDCl3),  6.13 (s, 1H, CHcage), 1.59 (s, 1H, 
CHcage), 1.74 (d, 2JPH = 12.0 Hz, 9H, CH3), 1.36 (d, 2JPH = 15.6 Hz, 9H, CH3).  31P{1H} NMR 
(CDCl3),  -9.2 (q, 1JPB = 145.8 Hz, 1P), -20.7 (s, 1P).  EIMS, envelope centred on m/z 519.9 
(M+). 
[1-(1′-1′,2′-closo-C2B10H11)-3,3-(PMe2Ph)2-3,1,2-closo-NiC2B9H10] (6) and [7-(1′-1′,2′-
closo-C2B10H11)-10-(PMe2Ph)-7,8-nido-C2B9H10] (7).  Salt [HNMe3]I (0.20 g, 0.59 mmol) 
was treated with n-BuLi (0.51 mL of 2.5M solution in hexanes, 1.29 mmol) as described 
previously and then frozen at -196 °C.  To this was added cis-[NiCl2(PMe2Ph)2] (0.25 g, 0.64 
mmol) and the reaction mixture stirred overnight at room temperature.  All volatiles were 
removed in vacuo and the crude mixture dissolved in DCM and filtered through Celite®.  
Preparative TLC using an eluent system of DCM and petrol in a ratio of 40:60 afforded a green 
band (Rf = 0.45) subsequently identified as [1-(1′-1′,2′-closo-C2B10H11)-3,3-(PMe2Ph)2-3,1,2-
closo-NiC2B9H10] (6) (0.093 g, 25%).  C20H43B19P2Ni requires C 39.4, H 7.11.  Found for 5 C 
38.8, H 7.20%.  11B{1H} NMR (CDCl3),  1.6 (1B), -0.7 (1B), -2.4 (1B), -4.7 (1B), -8.7 to -16.2 
multiple overlapping resonances with maxima at -8.7, -9.7, -12.1, -16.2 (total integral of last 
four resonances 14B), -21.6 (1B).  1H NMR (CDCl3),  7.83 (m, 2H, C6H5), 7.58-7.38 (m, 8H, 
C6H5), 4.00 (s, 1H, CHcage), 1.74 (d, 2JPH = 10.0 Hz, 3H, CH3), 1.54 (d, 3H, CH3, signal partially 
obscurred by water), 1.37 (d, 2JPH = 8.0 Hz, 3H, CH3), 1.18 (d, 3JPH = 14.0 Hz, 1H, CHcage), 1.07 
(d, 2JPH = 10.0 Hz, 3H, CH3).  1H{31P} NMR (CDCl3),  7.84 (m, 2H, C6H5), 7.58-7.38 (m, 8H, 
C6H5), 4.00 (s, 1H, CHcage), 1.75 (s, 3H, CH3), 1.54 (s, 3H, CH3), 1.38 (s, 3H, CH3), 1.16 (s, 1H, 
CHcage), 1.09 (s, 3H, CH3).  31P{1H} NMR (CDCl3),  -4.8 (d, 2JPP = 39.7 Hz, 1P), -14.9 (d, 2JPP 
= 39.7 Hz, 1P).  EIMS, envelope centred on m/z 609.3 (M+). 
A trace amount of purple band (Rf = 0.50) was also obtained, crystallisation of which 
revealed both purple and colourless solids, the latter in sufficient amount for it to be identified 
as [7-(1′-1′,2′-closo-C2B10H11)-10-(PMe2Ph)-7,8-nido-C2B9H10] (7).  C12H32B19P requires C 
34.9, H 7.81.  Found for 7 C 34.4, H 7.23%.  11B{1H} NMR [CDCl3],  -2.7 (1B), -4.9 (1B), -8.5 
to -18.4 multiple overlapping resonances with maxima 
at -8.5, -9.8, -10.7, -13.2, -15.0, -16.4, -17.5 (total integral of last seven resonances 15B), -33.4 
(1B), -34.2 (1B).  1H NMR (CDCl3),  7.76-7.65 (m, 5H, C6H5), 3.66 (s, 1H, CHcage), 2.49 (s, 
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1H, CHcage), 1.79 (d, 2JPH = 10.8 Hz, 6H, CH3).  1H{31P} NMR (CDCl3), 7.76-7.65 (m, 5H, 
C6H5), 3.66 (s, 1H, CHcage), 2.49 (s, 1H, CHcage), 1.79 (s, 6H, CH3).  1H{11B} NMR (CDCl3), 
includes  -1.93 (br s, 1H, -H).  31P{1H} NMR (CDCl3),  -8.8 (q, 1JPB = 148.5 Hz).  EIMS, 
envelope centred on m/z 412.7 (M+). 
[2-(1′-1′,2′-closo-C2B10H11)-4,4-(PMePh2)2-4,1,2-closo-NiC2B9H10] (8).  Salt [HNMe3]I 
(0.20 g, 0.59 mmol) was deprotonated with n-BuLi (0.51 mL of 2.5M solution in hexanes, 1.29 
mmol) as above and frozen at -196 °C.  Cis-[NiCl2(PMePh2)2] (0.33 g, 0.64 mmol) added and 
the reaction mixture stirred overnight at room temperature.  THF was removed in vacuo and 
the crude mixture dissolved in DCM and filtered through Celite®.  Preparative TLC using an 
eluent system of DCM and petrol in a ratio of 40:60 afforded an olive-green band (Rf = 0.48) 
subsequently identified as [2-(1′-1′,2′-closo-C2B10H11)-4,4-(PMePh2)2-4,1,2-closo-NiC2B9H10] 
(8) (0.090 g, 20%).  C30H47B19NiP2 requires C 49.1, H 6.46; C30H47B19NiP2·CH2Cl2 requires C 
45.5, H 5.92; C30H47B19NiP2·0.5CH2Cl2 requires C 47.2, H 6.23.  Found for 6 C 47.2, H 6.91%.  
11B{1H} NMR [(CD3)2CO],  5.1 (1B), -1.6 to -17.3 multiple overlapping resonances with 
maxima at -1.6, -3.2, -6.9, -10.4, -13.1, -15.0, -17.3 (total integral of last seven resonances 18B).  
1H NMR [(CD3)2CO],  7.73-7.67 (m, 4H, C6H5), 7.49-7.18 (m, 16H, C6H5), 4.13 (s, 1H, 
CHcage), 2.82 (s, 1H, CHcage), 1.89 [d + d (app. t), 2JPH = ca. 5 Hz, 5Hz, 6H, CH3) 24.  1H{31P} 
NMR [(CD3)2CO],  7.72-7.23 (m, 20H, C6H5), 4.11 (s, 1H, CHcage), 2.81 (s, 1H, CHcage), 1.89 
(s, 6H, CH3).  31P{1H} NMR [(CD3)2CO],  13.9 (s).  EIMS, envelope centred on m/z 733.4 
(M+). 
cis-[NiBr2{P(OMe)3}2].  By analogy with the related tris(triethylphosphite) species,16 
anhydrous NiBr2 (0.50 g, 2.29 mmol) was stirred for 0.5 hr in THF (20 mL) affording a 
brownish-orange solution.  P(OMe)3 (0.54 mL, 4.58 mmol) was added to the solution which 
immediate changed to dark purple.  The reaction mixture was stirred at room temperature for a 
further 2 hr.  THF was removed in vacuo and the remaining dried under vacuum to afford a 
brown powder, cis-[NiBr2{P(OMe)3}2] (0.76 g, 71%).  C6H18Br2NiO6P2 requires C 15.4, H 
3.89.  Found: C 16.1, H 4.38%.  1H NMR (CDCl3),  3.87 (br. s, OCH3).  31P NMR (CDCl3), 
(br. s). 
[1-(1′-1′,2′-closo-C2B10H11)-3,3-{P(OMe)3}2-3,1,2-closo-NiC2B9H10] (9).  Salt [HNMe3]I 
(0.15 g, 0.45 mmol) was lithiated with n-BuLi (0.36 mL of 2.5M solution in hexanes, 0.90 
mmol) as above and frozen at -196 °C.  [Ni3(tmeda)3Cl5]Cl (0.11 g, 0.15 mmol) was added and 
the reaction mixture allowed to stir to produce a greenish-blue solution.  P(OMe)3 (0.53 mL, 
4.50 mmol) was added dropwise and the reaction mixture stirred overnight at room temperature 
during which the solution turned brown.  THF was removed in vacuo and the crude mixture 
dissolved in DCM and filtered through Celite®.  Preparative TLC using an eluent system of 
DCM and petrol, 50:50, afforded a purple band (Rf = 0.38) subsequently identified as [1-(1′-
16 
1′,2′-closo-C2B10H11)-3,3-{P(OMe)3}2-3,1,2-closo-NiC2B9H10] (9) (0.045 g, 17%).  
C10H39B19NiO6P2 requires C 20.7, H 6.76.  Found for 9 C 20.5, H 6.93%.  11B{1H} NMR 
(CDCl3),  1.3 (1B), -0.6 (1B), -2.2 (1B), -4.6 (1B), -6.3 (1B), -9.7 to -14.0 multiple overlapping 
resonances with maxima at -9.7, -10.2, -13.1, -14.0 (total integral of last four resonances 
13B), -18.7 (1B).  1H NMR (CDCl3),  4.59 (s, 1H, CHcage), 3.85 [d + d (app. t), 3JPH = ca. 11.0 
Hz, 11.0 Hz, 18H, OCH3], 2.52 (d, 3JPH = 10.0 Hz, 1H, CHcage).  1H{31P} NMR (CDCl3),  4.58 
(s, 1H, CHcage), 3.87 (s, 9H, OCH3), 3.84 (s, 9H, OCH3), 2.52 (s, 1H, CHcage).  31P{1H} NMR 
(CDCl3),  117.4 (d, 2JPP = 118.2 Hz, 1P), 113.1 (d, 2JPP = 118.2 Hz, 1P).  EIMS, envelope 
centred on m/z 581.3 (M+). 
[1-(1′-1′,2′-closo-C2B10H11)-3,3-{P(OMe)3}2-3,1,2-closo-NiC2B9H10] (9) and [1-(1′-1′,2′-
closo-C2B10H11)-2,2-{P(OMe)3}2-2,1,8-closo-NiC2B9H10] (10). Salt [HNMe3]I (0.20 g, 0.59 
mmol) was lithiated with n-BuLi (0.47 mL of 2.5M solution in hexanes, 1.18 mmol) as above 
and frozen at -196 °C.  [Ni3(tmeda)3Cl5]Cl (0.22 g, 0.30 mmol) was added and the reaction 
mixture allowed to stir for 2 hr at room temperature to produce a greenish-blue solution.  
P(OMe)3 (0.70 mL, 5.90 mmol) was added dropwise to the solution and the reaction mixture 
stirred overnight at room temperature during which the solution turned brown.  THF was 
removed in vacuo and the crude mixture dissolved in DCM and filtered through Celite®.  
Preparative TLC using an eluent system of DCM and petrol (50:50) afforded a purple band (Rf 
= 0.36) identified spectroscopically as [1-(1′-1′,2′-closo-C2B10H11)-3,3-{P(OMe)3}2-3,1,2-
closo-NiC2B9H10] (9) (0.010 g, 3%) and a yellow band (Rf = 0.46) subsequently identified as 
[1-(1′-1′,2′-closo-C2B10H11)-2,2-{P(OMe)3}2-2,1,8-closo-NiC2B9H10] (10) (0.026 g, 13%). 
10: C10H39B19O6NiP2 requires C 20.7, H 6.76.  Found for 10: C 20.3, H 6.84%.  11B{1H} 
NMR (CDCl3),  -2.5 (1B), -5.6 (2B), -8.2 to -9.8 multiple overlapping resonances with maxima 
at -8.2, -9.8 (total integral of last two resonances 8B), -13.2 (4), -17.6 (2B), -18.4 (2B).  1H 
NMR (CDCl3),  4.32 (s, 1H, CHcage), 3.83 (d with additional structure, 3JPH = ca. 10.4 Hz, 9H, 
OCH3), 3.79 (d with additional structure, 3JPH = ca. 10.4 Hz, 9H, OCH3), 2.23 (s, 1H, CHcage).  
1H{31P} NMR (CDCl3),  4.31 (s, 1H, CHcage), 3.83 (s, 9H, OCH3), 3.79 (s, 9H, OCH3), 2.22 
(s, 1H, CHcage).  31P{1H} NMR (CDCl3),  125.2-123.5 (m, overlapping of two doublets, 1P 
each).  EIMS: envelope centred on m/z 580.3 (M+). 
Crystallography 
Diffraction-quality crystals of all compounds were obtained by solvent diffusion at -30 oC as 
follows (compound, solvent, antisolvent): 1 & 6, THF, petrol; 2-4 & 9, DCM, petrol; 5 & 7, 
CHCl3, petrol; 10, CDCl3, petrol.  Compound 1 was also crystallised from DCM/petrol to yield 
crystals of the solvate 1∙DCM with cell dimensions a = 10.1148(8), b = 21.057(2), c = 
11.1877(9) Å,  = 113.814(4)º, space group P21.  Data from this crystal afforded a structure 
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which was sub-publication quality but which nevertheless confirmed the ratio of 
nickelacarborane to DCM allowing the microanalytical results to be rationalised. 
Intensity data for were collected on a Bruker X8 APEXII diffractometer using Mo-K X-
radiation, with crystals mounted in inert oil on a cryoloop and cooled to 100 K (200 K in the 
case of compound 5) by an Oxford Cryosystems Cryostream.  Indexing, data collection and 
absorption correction were performed using the APEXII suite of programs.25 Using OLEX2 26 
structures were solved with the OLEX2.solve programme 27 (SHELXT 28 for compound 10) 
and refined by full-matrix least-squares (SHELXL).29 
Cage C atoms not involved in the intercage link were identified by a combination of (i) the 
examination of refined (as B) isotropic thermal parameters, (ii) the lengths of cage 
connectivities, (iii) the Vertex-Centroid Distance Method 30 and (iv) the Boron-H Distance 
Method,31 with all four methods affording excellent mutual agreement. 
All crystals were single except for 6 and 9, both two-component twins.  Compounds 5, 7 
and 8 are free of solvate and fully ordered.  In 1 the nickelacarborane is fully ordered but there 
is disordered solvent in the lattice that was impossible to model satisfactorily (only a fragment 
of THF could be identified).  Hence for this structure the intensity contribution of the disordered 
solvent was removed using the BYPASS procedure 32 implemented in OLEX2.  The total 
electron count of solvent per cell was 190 e which corresponds to approximately four THF plus 
0.5 hexane molecules.  These disordered solvent molecules predominantly occupy two voids of 
ca. 400 Å3 each.  The same procedure was also implemented for 4: total electron count of 
solvent per cell 123 e, ca. three CH2Cl2 per cell in two voids of ca. 209 Å3 each. 
The nickelacarboane in 2 is also ordered but there is one disordered molecule of CH2Cl2 of 
solvation per asymmetric unit, however in this case the disorder was modelled.  In 3 there is 
partial disorder of the C2B10 cage involving vertices 2′ (mainly C) and 3′ (mainly B) and also 
disorder of P2, the CH2CH2 bridge of the dmpe ligand and the C211H3 group.  In both 
compounds 4 and 6 there is C/B disorder in the nickelacarborane cage involving vertices 2 
(mainly C) and 4 (mainly B).  In the case of 4 this was successfully modelled with refining but 
tied site occupation factors (SOFs), but such an approach was not possible for 6 (the data set is 
comparatively poor) and fixed SOFs of 0.85 C + 0.15 B at vertex 2 and 0.15 C + 0.85 B at 
vertex 4 were used.  Finally, in 10 the C23 methyl group is disordered with two sets of H atoms 
with SOFs of 0.51(2) and 0.49(2). 
For all structures H atoms bound to cage B or C atoms, including the -H atom in compound 
7, were allowed to refine positionally whilst other H atoms were constrained to idealised 
geometries; Cphenyl–H = 0.95 Å, Cmethyl–H = 0.98 Å, Cmethylene–H = 0.99 Å.  All H displacement 
parameters, Uiso, were constrained to be 1.2×Ueq (bound B or C) except Me H atoms [Uiso(H) = 
1.5×Ueq C(Me)].  Table 1 contains further experimental details. 
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<Table 1 near here> 
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Fig. 1 The [7-(1′-1′,2′-closo-C2B10H11)-7,8-nido-C2B9H10]2– dianion (abbreviated [I-H]2– in 
text). 
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Fig. 2 Perspective view of compound 1 with atomic numbering scheme.  Displacement 
ellipsoids are drawn at the 50% probability level except for H atoms. 
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Fig. 3 Perspective view of compound 2 with atomic numbering scheme.  Displacement 
ellipsoids as in Fig. 2. 
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Fig. 4 Perspective view of compound 3 with atomic numbering scheme.  Only the major 
components of the partial disorder are shown.  Displacement ellipsoids as in Fig. 2. 
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Fig. 5 Perspective view of compound 4 with atomic numbering scheme.  Only the major 
components of the partial disorder are shown.  Displacement ellipsoids as in Fig. 2. 
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Fig. 6 Perspective view of compound 5 with atomic numbering scheme.  Displacement 
ellipsoids as in Fig. 2. 
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Fig. 7 Perspective view of compound 6 with atomic numbering scheme.  Only the major 
components of the partial disorder are shown.  Displacement ellipsoids as in Fig. 2. 
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Fig. 8 Perspective view of compound 7 with atomic numbering scheme.  Displacement 
ellipsoids as in Fig. 2. 
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Fig. 9 Comparison of the 11B{1H} NMR spectra of compound 8, 2 and 3 between +28 and –40 ppm. 
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Fig. 10 Perspective view of compound 9 with atomic numbering scheme.  Displacement 
ellipsoids as in Fig. 2. 
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Fig. 11 Perspective view of compound 10 with atomic numbering scheme.  Only the major 
component of the disordered C23H3 group is shown.  Displacement ellipsoids as in 
Fig. 2. 
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Scheme 1 Reaction between [I-H]2− and [NiCl2PP] (PP = chelating diphosphine). 
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Scheme 2 Reaction between [I-H]2− and [NiCl2P2] (P = monodentate phosphine). 
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Scheme 3 Reaction between [I-H]2− and sources of the {Ni[P(OMe)3]2}2+ fragment. 
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Table 1 Crystallographic data. 
 
 1 2 3 4 
Formula C30H45B19NiP2∙C4.75H9.75O C30H45B19NiP2∙CH2Cl2 C10H37B19NiP2 C10H39B19NiP2∙C0.75H1.5Cl1.5 
M 814.57 816.62 483.49 549.14 
Crystal system monoclinic triclinic triclinic monoclinic 
Space group P21/n Pbar1 Pbar1 P21/n 
a/Å 15.9009(8) 10.2951(8) 9.0457(7) 10.3294(7) 
b/Å 15.8294(8) 13.7359(10) 12.1143(10) 29.295(2) 
c/Å 18.1091(8) 16.4159(13) 13.0918(11) 10.5038(7) 
/º 90 70.135(4) 112.101(4) 90 
/º 109.606(2) 74.434(4) 97.903(4) 116.545(3) 
/º 90 74.312(4) 99.226(4) 90 
U/Å3 4293.8(4) 2061.6(3) 1280.96(18) 2843.4(4) 
Z, Z′ 4, 1 2, 1 2, 1 4, 1 
F(000)/e 1697 840 500 1134 
Dcalc/Mg m–3 1.260 1.315 1.254 1.134 
(Mo-K)/mm–1 0.557 0.704 0.883 0.940 
max/º 28.08 33.99 28.33 27.77 
Data measured 71344 59426 21467 48075 
Unique data, n 10294 16558 6101 6682 
Rint 0.0994 0.0417 0.0328 0.0575 
R, wR2 (obs. data) 0.0429, 0.0974 0.0436, 0.0999 0.0342, 0.0759 0.0348, 0.0847 
S (all data) 0.969 1.030 0.980 1.072 
Variables 532 572 384 359 
Emax, Emin/e Å
–3 0.37, –0.71 1.23, –0.89 0.76, –0.62 0.35, –0.30 
Flack parameter     
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Table 1 contd. 
 
5 6 7 9 10 
C10H38B19ClNiP2 C20H43B19NiP2 C12H32B19P C10H39B19NiO6P2 C10H39B19NiO6P2 
519.89 609.58 412.73 581.45 581.45 
monoclinic monoclinic monoclinic triclinic triclinic 
P21/n P21 P21/c Pbar1 Pbar1 
11.2413(5) 9.8159(13) 7.0021(9) 11.0321(11) 10.2399(12) 
13.8817(6) 11.0792(15) 12.7125(16) 11.6703(12) 10.9998(13) 
18.1169(7) 14.558(2) 26.754(3) 11.8503(11) 13.1020(15) 
90 90 90 109.302(4) 78.50297) 
97.664(2) 90.703(9) 95.459(3) 95.518(5) 89.803(6) 
90 90 90 93.573(6) 78.700(6) 
2801.9(2) 1583.1(4) 2370.7(5) 1426.1(2) 1417.1(3) 
4, 1 2, 1 4, 1 2, 1 2, 1 
1072 632 856 600 600 
1.232 1.279 1.156 1.345 1.363 
0.904 0.729 0.117 0.820 0.826 
28.56 25.98 28.28 26.05 31.09 
50624 17876 15432 28465 33480 
7045 4833 5764 5415 8810 
0.0520 0.1330 0.0548 0.0850 0.0487 
0.0331, 0.0862 0.0699, 0.1353 0.0587, 0.1334 0.0419, 0.0992 0.0376, 0.0809 
1.039 1.047 1.026 1.020 1.057 
364 441 355 413 412 
0.38, –0.30 0.53, –0.51 0.58, –0.43 0.45, –0.51 0.43, –0.58 
 0.44(4)    
 
 
  
36 
References 
1. J. A. Dupont and M. F. Hawthorne, J. Am. Chem. Soc., 1964, 86, 1643. 
2. W. Y. Man, G. M. Rosair and A. J. Welch, Acta Cryst., 2014, E70, 462. 
3. G. Thiripuranathar, W. Y. Man, C. Palmero, A. P. Y. Chan, B. T. Leube, D. Ellis, D. 
McKay, S. A. Macgregor, L. Jourdan, G. M. Rosair and A. J. Welch, Dalton Trans., 2015, 
44, 5628. 
4. (a) T. E. Paxson, M. K. Kaloustian, G. M. Tom, R. J. Wiersema and M. F. Hawthorne, J. 
Am. Chem. Soc., 1972, 94, 4882; (b) T. P. Hanusa and L. J. Todd, Polyhedron, 1985, 4, 
2063. 
5. R. E. King, S. B. Miller, C. B. Knobler and M. F. Hawthorne, Inorg. Chem., 1983, 22, 
3548. 
6. Initially EHMO calculations were used to analyse both the ML2 orientation and the related 
slip distortion: see (a) D. M. P. Mingos, M. I. Forsyth and A. J. Welch, J. Chem. Soc., 
Chem. Commun., 1977, 605; (b) idem, J. Chem. Soc., Dalton Trans., 1978, 1363.  More 
recently the slip distortion was analysed at the DFT level of theory with energy 
decomposition analysis emphasising the importance of steric factors in this distortion: see 
P. D. Abram, D. McKay, D. Ellis, S. A. Macgregor, G. M. Rosair and A. J. Welch, Dalton 
Trans., 2010, 39, 2412. 
7. E. W. Abel, J. K. Bhargava and K. G. Orrell, Prog. Inorg. Chem., 1984, 32, 1. 
8. (a) M. R. Churchill and K. Gold, J. Am. Chem. Soc., 1970, 92, 1180; (b) N. Carr, D. F. 
Mullica, E. L. Sappenfield and F. G. A. Stone, Inorg. Chem., 1994, 33, 1666; (c) K. Fallis, 
D. F. Mullica, E. L. Sappenfield and F. G. A. Stone, Inorg. Chem., 1994, 33, 4927; (d) R. 
M. Garrioch, P. Kuballa, K. S. Low, G. M. Rosair and A. J. Welch, J. Organomet. Chem., 
1999, 575, 57; (e) M. A. Fox, J. A. K. Howard, A. K. Hughes, J. M. Malget and D. S. 
Yufit, J. Chem. Soc., Dalton Trans., 2001, 2263; (f) S. Robertson, D. Ellis, G. M. Rosair 
and A. J. Welch, Appl. Organomet. Chem., 2003, 17, 518; (g) S. Robertson, R. M. 
Garrioch, D. Ellis, T. D. McGrath, B. E. Hodson, G. M. Rosair and A. J. Welch, Inorg. 
Chim. Acta, 2005, 358, 1485; (h) W. Y. Man, G. M. Rosair and A. J. Welch, Dalton Trans., 
2015, 44, 15417. 
9. C. R. Groom and F. H. Allen, Angew. Chem. Int. Ed., 2014, 53, 662. 
10. e.g. D. McKay, S. A. Macgregor and A. J. Welch, Chem. Sci., 2015, 6, 3117. 
11. J. Buchanan, E. J. M. Hamilton, D. Reed and A. J. Welch, J. Chem. Soc., Dalton Trans., 
1990, 677. 
12. L. I. Zakharkin, V. a. Olshevskaya, G. G. Zhigareva, V. A. Antonovich, P. V. Perovskii, 
A. I. Yanovskii, A. V. Polyakov and Yu. T. Struchkov, Metallorg. Khim., 1989, 2, 1274. 
13. S. A. Jasper Jr., J. Mattern, J. C. Huffman and L. J. Todd, Polyhedron, 2007, 26, 3793. 
37 
14. C. A. Tolman, Chem. Rev., 1977, 77, 313. 
15. L. J. Vande Griend, J. C. Clardy and J. G. Verkade, Inorg. Chem., 1975, 14, 710. 
16. M. M. Lindner, U. Beckmann, W. Frank and W. Klaui, ISRN Inorg. Chem., 2013, 2013, 
1. 
17. (a) H. M. Colquhoun, T. J. Greenhough and M. G. H. Wallbridge, J. C. S. Chem. Comm., 
1978, 322; (b) idem, J. Chem. Soc., Dalton Trans., 1985, 761. 
18. D. A. Handley, P. B. Hitchcock and G. J. Leigh, Inorg. Chim. Acta, 2001, 314, 1. 
19. D. R. Baghurst, R. C. B. Copley, H. Fleischer, D. M. P. Mingos, G. O. Kyd, L. J. 
Yellowlees, A. J. Welch, T. R. Spalding and D. O'Connell, J. Organomet. Chem., 1993, 
447, C14. 
20. In principle we might also have expected to form a 8-C2B10-2,1,8-NiC2B9 species from the 
reaction which affords compound 10 but such a species was not isolated. 
21. S. Ren and Z. Xie, Organometallics, 2008, 27, 5167. 
22. G. Booth and J. Chatt, J. Chem. Soc., 1965, 3238. 
23. (a) L. M. Venanzi, J. Chem. Soc., 1958, 719; (b) G. Booth and J. Chatt, J. Chem. Soc., 
1960, 1718. 
24. See compound 4 in R. E. King, S. B. Miller, C. B. Knobler and M. F. Hawthorne, Inorg. 
Chem., 1983, 22, 3548. 
25. Bruker AXS APEX2, version 2009-5, Bruker AXS Inc., Madison, Wisconsin, USA, 2009. 
26. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann, J. Appl. 
Cryst., 2009, 42, 339. 
27. L. J. Bourhis, O. V. Dolomanov, R. J. Gildea, J. A. K. Howard and H. Puschmann, Acta 
Cryst., 2015, A71, 59. 
28. G. M. Sheldrick, Acta Cryst., 2015, A71, 3. 
29. G. M. Sheldrick, Acta Cryst., 2008, A64, 112. 
30. A. McAnaw, G. Scott, L. Elrick, G. M. Rosair and A. J. Welch, Dalton Trans., 2013, 42, 
645. 
31. A. McAnaw, M. E. Lopez, D. Ellis, G. M. Rosair and A. J. Welch, Dalton Trans., 2014, 
43, 5095. 
32. (a) P. van der Sluis and A. L. Spek, Acta Cryst., 1990, A46, 194; (b) A. L. Spek, J. Appl. 
Cryst., 2003, 36, 7. 
 
